Literature DB >> 11825978

Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.

Enrico Tortoli1, Marta Benedetti, Alessandra Fontanelli, M Tullia Simonetti.   

Abstract

We evaluated the performance of BACTEC MGIT 960 for automated testing of the susceptibility of 133 strains of Mycobacterium tuberculosis to streptomycin, isoniazid, rifampin, and ethambutol. The BACTEC MGIT 960 results were compared with those obtained with the radiometric BACTEC 460TB system, and when there was disagreement, the method of proportion on agar plates was used as a reference method. Strains resistant to the critical concentration of streptomycin, isoniazid, or ethambutol were also tested with a second, higher concentration. The overall agreement between the two systems was 96.7%, and the 18 discrepancies were resolved in favor of BACTEC 460TB in 11 cases and in favor of BACTEC MGIT 960 in 7, a difference which was not statistically significant. Apart from the assay's low specificity for ethambutol, which was low for the radiometric assay as well, good sensitivity and specificity values characterized BACTEC MGIT 960. The average time required for completion of the test was 2.5 days shorter with BACTEC 460TB. In conclusion, BACTEC MGIT 960 appears to be a suitable replacement for the radiometric method of antimicrobial susceptibility testing of M. tuberculosis. The problem of frequent contamination of BACTEC MGIT 960 tests needs to be quickly resolved; in fact, 14 strains had to be reprocessed because of contamination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825978      PMCID: PMC153389          DOI: 10.1128/JCM.40.2.607-610.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method.

Authors:  P Ruiz; F J Zerolo; M J Casal
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Evaluation of mycobacteria growth indicator tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens.

Authors:  M Palaci; S Y Ueki; D N Sato; M A Da Silva Telles; M Curcio; E A Silva
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.

Authors:  J S Bergmann; G L Woods
Journal:  Diagn Microbiol Infect Dis       Date:  1997-07       Impact factor: 2.803

4.  Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks.

Authors:  L G Wayne; I Krasnow
Journal:  Am J Clin Pathol       Date:  1966-06       Impact factor: 2.493

Review 5.  Epidemiology of resistant tuberculosis in Europe.

Authors:  S Rüsch-Gerdes
Journal:  Infection       Date:  1999       Impact factor: 3.553

6.  Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Authors:  E Tortoli; P Cichero; C Piersimoni; M T Simonetti; G Gesu; D Nista
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  Comparison of the MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria from various clinical specimens.

Authors:  F Brunello; F Favari; R Fontana
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems.

Authors:  E Tortoli; R Mattei; A Savarino; L Bartolini; J Beer
Journal:  Diagn Microbiol Infect Dis       Date:  2000-10       Impact factor: 2.803

9.  Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens.

Authors:  G D Roberts; N L Goodman; L Heifets; H W Larsh; T H Lindner; J K McClatchy; M R McGinnis; S H Siddiqi; P Wright
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  Testing of susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by mycobacterium growth indicator tube method.

Authors:  S B Walters; B A Hanna
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  38 in total

1.  Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  M Espasa; M Salvadó; E Vicente; G Tudó; F Alcaide; P Coll; N Martin-Casabona; M Torra; D Fontanals; J González-Martín
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

2.  Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.

Authors:  Meenu Sharma; Louise Thibert; Pamela Chedore; Cary Shandro; Frances Jamieson; Gregory Tyrrell; Sara Christianson; Hafid Soualhine; Joyce Wolfe
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

3.  Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  Jim Werngren; Lisbeth Klintz; Sven E Hoffner
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 4.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

5.  Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  Shunji Takakura; Shigeo Tsuchiya; Naoko Fujihara; Toyoichiro Kudo; Yoshitsugu Iinuma; Satoshi Mitarai; Satoshi Ichiyama; Kiyoshi Yasukawa; Takahiko Ishiguro
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 6.  Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Authors:  Claudio Piersimoni; Armando Olivieri; Luca Benacchio; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

7.  Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Malcolm D Yates; Francis A Drobniewski
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.

Authors:  Chiyoji Abe; Ikuo Kobayashi; Satoshi Mitarai; Masako Wada; Yoshiko Kawabe; Tetsuya Takashima; Katsuhiro Suzuki; Li-Hwei Sng; Suxing Wang; Hla Hla Htay; Hideo Ogata
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

9.  Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.

Authors:  S-Y Grace Lin; Edward Desmond; Donald Bonato; Wendy Gross; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

10.  An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia.

Authors:  Yanina Balabanova; Francis Drobniewski; Vladyslav Nikolayevskyy; Annika Kruuner; Nadezhda Malomanova; Tatyana Simak; Nailya Ilyina; Svetlana Zakharova; Natalya Lebedeva; Heather L Alexander; Rick O'Brien; Hojoon Sohn; Anastasia Shakhmistova; Ivan Fedorin
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.